Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Transition Care for Young People with Rare Bone and Mineral Conditions: A Scoping Review.

Advances in therapy·2026
Same author

Transition Care for Young People with Rare Bone and Mineral Conditions: A Scoping Review.

Advances in therapy·2026
Same author

Are socioeconomic, social and built neighbourhood characteristics associated with persistence of depression over 2 years?

Journal of affective disorders·2026
Same author

Associations between estradiol levels and subjective sleep parameters in a large cohort of men and women.

Endocrine connections·2026
Same author

Assessment of Collagen and Fibroblast Properties via Label-Free Higher Harmonic Generation Microscopy in Three-Dimensional Models of Osteogenesis Imperfecta and Ehlers-Danlos Syndrome.

International journal of molecular sciences·2025
Same author

Late-career workforce participation in times of rising state pension age: the role of health and motivation.

BMC public health·2025

Related Experiment Video

Updated: May 9, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

PTH: a new target in arteriosclerosis?

Petra J Buizert1, Natasja M van Schoor, Suat Simsek

  • 1PhD, Internist-Endocrinologist, Department of Endocrinology, VU University Medical Center, Box 7057, 1007 MB Amsterdam, The Netherlands. emw.eekhoff@vumc.nl.

The Journal of Clinical Endocrinology and Metabolism
|August 10, 2013
PubMed
Summary
This summary is machine-generated.

Elevated parathyroid hormone (PTH) levels within the normal range are linked to increased cardiovascular disease (CVD) risk in older adults. This association may be partly explained by abdominal aortic calcifications in men.

More Related Videos

Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography
11:45

Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography

Published on: May 26, 2015

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Related Experiment Videos

Last Updated: May 9, 2026

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography
11:45

Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography

Published on: May 26, 2015

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Geriatrics

Background:

  • Growing evidence links hyperparathyroidism to cardiovascular risks.
  • The relationship between normal serum PTH levels and cardiovascular diseases (CVD) is not well understood.

Purpose of the Study:

  • To investigate the association between serum PTH levels within the normal range and CVD.
  • To examine the link between normal serum PTH levels and abdominal aortic calcifications.

Main Methods:

  • Cross-sectional, population-based study using data from the Longitudinal Aging Study Amsterdam.
  • Included 558 men and 537 women aged 65-88 years.
  • Adjusted for multiple potential confounders including demographics, lifestyle, and biochemical factors.

Main Results:

  • Higher serum PTH levels within the normal range were significantly associated with increased CVD risk (OR 2.22).
  • A significant association between PTH and abdominal aortic calcifications was found in men (OR 4.03).
  • The association between PTH and aortic calcifications in men remained significant after confounder adjustment.

Conclusions:

  • Serum PTH levels in the upper normal range are strongly associated with CVD in older individuals.
  • Abdominal aortic calcifications may partially mediate the PTH-CVD link in men.
  • Further research is warranted to understand the role of serum PTH in CVD and arteriosclerosis.